Influence of Passive Permeability on Apparent P-glycoprotein Kinetics
暂无分享,去创建一个
James E. Polli | Stephen A. Wring | Joseph W. Polli | J. Polli | J. Polli | J. Humphreys | S. Wring | Kimberley A. Lentz | Joan E. Humphreys | K. Lentz
[1] P Langguth,et al. Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein. , 1999, Journal of pharmaceutical sciences.
[2] R. Conradi,et al. A biophysical model of passive and polarized active transport processes in Caco-2 cells: approaches to uncoupling apical and basolateral membrane events in the intact cell. , 1995, Journal of pharmaceutical sciences.
[3] Y. Assaraf,et al. The Role of Passive Transbilayer Drug Movement in Multidrug Resistance and Its Modulation* , 1996, The Journal of Biological Chemistry.
[4] B. Hirst,et al. Drug Absorption Limited by P-Glycoprotein-Mediated Secretory Drug Transport in Human Intestinal Epithelial Caco-2 Cell Layers , 1993, Pharmaceutical Research.
[5] J. Polli,et al. Development of a more rapid, reduced serum culture system for Caco-2 monolayers and application to the biopharmaceutics classification system. , 2000, International journal of pharmaceutics.
[6] Yuichi Sugiyama,et al. Effects of Intestinal CYP3A4 and P-Glycoprotein on Oral Drug Absorption—Theoretical Approach , 1999, Pharmaceutical Research.
[7] L. Reuss,et al. Unidirectional fluxes of rhodamine 123 in multidrug-resistant cells: evidence against direct drug extrusion from the plasma membrane. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[8] W. T. Beck,et al. Effect of modulators on the ATPase activity and vanadate nucleotide trapping of human P-glycoprotein. , 1998, Biochemical pharmacology.
[9] I. Pastan,et al. Kinetic evidence suggesting that the multidrug transporter differentially handles influx and efflux of its substrates. , 1994, Molecular pharmacology.
[10] V. Ling,et al. Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities. , 1997, European journal of biochemistry.
[11] Y. Assaraf,et al. Efficiency of P-glycoprotein-mediated exclusion of rhodamine dyes from multidrug-resistant cells is determined by their passive transmembrane movement rate. , 1997, European journal of biochemistry.
[12] I. Pastan,et al. Human P-glycoprotein exhibits reduced affinity for substrates during a catalytic transition state. , 1998, Biochemistry.
[13] G. Sawada,et al. Novel, highly lipophilic antioxidants readily diffuse across the blood-brain barrier and access intracellular sites. , 1999, The Journal of pharmacology and experimental therapeutics.
[14] R. Evers,et al. Transport of glutathione prostaglandin A conjugates by the multidrug resistance protein 1 , 1997, FEBS letters.
[15] G. Koren,et al. Modeling of P-glycoprotein-involved epithelial drug transport in MDCK cells. , 1999, American journal of physiology. Renal physiology.
[16] J. Tolan,et al. MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening. , 1999, Journal of pharmaceutical sciences.